Alx Oncology Holdings Inc

ALXO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001810182

SEC filings (opens in a new tab)

In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Alx Oncology Holdings Inc changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of ALXO: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	76	1	93	+18
Shares	33.3M	20.0K	45.8M	+12.5M (+37.6%)
Value	$159.8M	$96.0K	$681.5M	+$521.8M (+326.8%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Alx Oncology Holdings Inc at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to ALXO in Q4 2023
Institution	Shares	Value	% of portfolio
Vestal Point Capital, LP	1,655,000	$24.6M	2.61%
MPM Oncology Impact Management LP	1,264,759	$18.8M	4.41%
Point72 Asset Management, L.P.	913,700	$13.6M	0.04%
Price T Rowe Associates Inc	543,243	$8.09M	0.00%
Invesco Ltd.	385,232	$5.74M	0.00%
Adage Capital Partners GP, L.L.C.	160,000	$2.38M	0.00%
Schonfeld Strategic Advisors LLC	104,600	$1.56M	0.01%
Susquehanna Portfolio Strategies, LLC	90,957	$1.35M	0.02%
Wellington Management Group LLP	80,688	$1.20M	0.00%
Walleye Capital LLC	77,830	$1.16M	0.02%
TD Asset Management Inc	70,400	$1.05M	0.00%
Standard Life Aberdeen plc	66,211	$985.9K	0.00%
Two Sigma Investments, LP	65,921	$981.6K	0.00%
Cubist Systematic Strategies, LLC	65,814	$980.0K	0.01%
Manufacturers Life Insurance Company, The	48,059	$715.6K	0.00%
Jane Street Group, LLC	43,598	$649.2K	0.00%
ExodusPoint Capital Management, LP	30,391	$453.0K	0.01%
Jump Financial, LLC	24,946	$371.4K	0.01%
Walleye Trading LLC	23,032	$342.9K	0.01%
MetLife Investment Management	14,561	$216.8K	0.00%
Dynamic Technology Lab Private Ltd	14,389	$215.0K	0.02%
Connor, Clark & Lunn Investment Management Ltd.	13,309	$198.2K	0.00%
Marshall Wace, LLP	11,569	$172.3K	0.00%
Voya Investment Management LLC	10,708	$159.4K	0.00%
Quantbot Technologies LP	5,600	$83.4K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	1,907	$28.4K	0.00%
Metropolitan Life Insurance Co	1,579	$23.5K	0.00%
Lindbrook Capital, LLC	282	$4.20K	0.00%
Private Wealth Management Group, LLC	98	$1.46K	0.00%
Capital Advisors, Ltd. LLC	79	$1.00K	0.00%
Signaturefd, LLC	20	$298	0.00%
Farther Finance Advisors, LLC	4	$60	0.00%

Sold out (14)

Institutions that held Alx Oncology Holdings Inc at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of ALXO in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Braidwell LP	1,249,900	$6.00M
Logos Global Management LP	1,000,000	$4.80M
State of Wisconsin Investment Board	94,400	$453.1K
Cornercap Investment Counsel Inc	35,071	$168.3K
Alps Advisors Inc	30,358	$145.7K
Trexquant Investment LP	14,269	$68.5K
Zacks Investment Management	13,918	$66.8K
Forefront Analytics, LLC	13,769	$66.1K
Verition Fund Management LLC	11,649	$55.9K
Two Sigma Advisers, LP	11,600	$55.7K
Prelude Capital Management, LLC	10,900	$52.3K
XTX Topco Ltd	10,740	$51.6K
Group One Trading, L.P.	1,932	$9.27K
Newbridge Financial Services Group, Inc.	22	$106

Not filed for Q4 2023 yet (1)

Institutions that held Alx Oncology Holdings Inc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ALXO in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
First Republic Investment Management, Inc.	20,000	$96.0K